ArticleFrontiers in public health2025
Exploring the medical ethical limitations of GPT-4 in clinical decision-making scenarios: a pilot survey.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to conduct an examination of GPT-4's tendencies when confronted with ethical dilemmas, as well as to ascertain their ethical limitations within clinical decision-makings. Methods: Ethical dilemmas were synthesized and organized into 10 different scenarios. To assess the responses of GPT-4 to these dilemmas, a series of iterative and constrained prompting methods were employed. Custom questionnaire analysis and principal adherence analysis were employed to evaluate the GPT-4-generated responses. Questionnaire analysis was used to assess GPT-4's ability to provide clinical decision-making recommendations, while principal adherence analysis evaluated its alignment with to ethical principles. Error analysis was conducted on GPT-4-generated responses. Results: The questionnaire analysis (5-point Likert scale) showed GPT-4 achieving an average score of 4.49, with the highest scores in the Physical Disability scenario (4.75) and the lowest in the Abortion/Surrogacy scenario (3.82). Furthermore, the principal adherence analysis showed GPT-4 achieved an overall consistency rate of 86%, with slightly lower performance (60%) observed in a few specific scenarios. Conclusion: At the current stage, with the appropriate prompt techniques, GPT-4 can offer proactive and comprehensible recommendations for clinical decision-making. However, GPT-4 exhibit certain errors during this process, leading to inconsistencies with ethical principles and thereby limiting its deeper application in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.